Contrasting within-and between-host immune selection shapes Neisseria Opa repertoires

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Watkins, Eleanor R ^a   Grad, Yonatan H ^b   Gupta, Sunetra ^a   Buckee, Caroline O ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ANTIGEN; OPA PROTEIN, NEISSERIA; OUTER MEMBRANE PROTEIN;

GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; INNATE IMMUNITY; MOLECULAR EVOLUTION; NEISSERIA MENINGITIDIS; PATHOGENICITY;

ADHESINS, BACTERIAL; ANTIGENS; BACTERIAL OUTER MEMBRANE PROTEINS; EVOLUTION, MOLECULAR; HIV; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; NEISSERIA MENINGITIDIS;

EID: 84923337430     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06554     Document Type: Article

References (60)

1. Wisniewski-Dye, F. & Vial, L. Phase and antigenic variation mediated by genome modifications. Anton. Leeuw. Int. J. G. 94, 493-515 (2008).
2. Watkins, E. R. & Maiden, M. C. J. Persistence of Hyperinvasive Meningococcal Strain Types during Global Spread as Recorded in the PubMLST Database. Plos One 7, e45349 (2012).
3. Buckee, C. O., Gupta, S., Kriz, P., Maiden, M. C. J. & Jolley, K. A. Long-term evolution of antigen repertoires among carried meningococci. Proc. Biol. Sci. 277, 1635-1641 (2010).
4. Van der Ploeg, L. H., Schwartz, D. C., Cantor, C. R. & Borst, P. Antigenic variation in Trypanosoma brucei analyzed by electrophoretic separation of chromosomesized DNA molecules. Cell 37, 77-84 (1984).
5. Edmunds, W. J., Kafatos, G.,Wallinga, J.Mossong, J. R. Mixing patterns and the spread of close-contact infectious diseases. Emerg. Themes Epidemiol. 3, 10-10 (2006).
6. Liljeros, F., Edling, C. R., Amaral, L. A. N., Stanley, H. E. & Aberg, Y. The web of human sexual contacts. Nature 411, 907-908 (2001).
7. Woolhouse, M. E. J. et al. Heterogeneities in the transmission of infectious agents: Implications for the design of control programs. Proc. Natl. Acad. Sci. USA 94, 338-342 (1997).
8. Anderson, R. M. & May, R. M. Infectious Diseases of Humans: Dynamics and Control. (Oxford Univ. Press, Oxford, UK, 1991).
9. Anderson, R. M. & Garnett, G. P. Mathematical models of the transmission and control of sexually transmitted diseases. Sex. Transm. Dis. 27, 636-643 (2000).
10. Lange, A. & Ferguson,N.M. Antigenic Diversity, Transmission Mechanisms, and the Evolution of Pathogens. Plos Comp. Biol. 5 (2009).
11. Brunham, R. C. & Plummer, F. A. A general model of sexually-transmitted disease epidemiology and its implications for control. Med. Clin. North Am. 74, 1339-1352 (1990).
12. McMichael, A. J. & Phillips, R. E. Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15, 271-296 (1997).
13. Ronald, A. Molecular and cell biology of sexually transmitted diseases-Wright, D., Archard, L. Soc. Sci. Med. 42, 784-784 (1996).
14. Lipsitch, M. & O'Hagan, J. J. Patterns of antigenic diversity and the mechanisms that maintain them. J. Roy. Soc. Interface 4, 787-802 (2007).
15. Buckee, C. O. et al. Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proc. Natl. Acad. Sci. USA 105, 15082-15087 (2008).
16. Gupta, S., Ferguson, N.& Anderson, R. Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 280, 912-915 (1998).
17. Antia, R., Nowak, M. A. & Anderson, R. M. Antigenic variation and the withinhost dynamics of parasites. Proc. Natl. Acad. Sci. USA 93, 985-989 (1996).
18. Nowak, M. A.,May, R. M. & Anderson, R.M. The evolutionary dynamics of hiv-1 quasispecies and the development of immunodeficiency disease. Aids 4, 1095-1103 (1990).
19. Trotter, C. L. & Greenwood, B. M. Meningococcal carriage in the African meningitis belt. Lancet Infect. Dis. 7, 797-803 (2007).
20. World Health Organisation. Global incidence and prevalence of selected curable sexually transmitted infections-2008 (2012). Dept. of Reproductive Health and Research. ISBN: 978 92 4 150383 9.
21. Chiu, C. et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun. Dis. Intell. 34 Supp, S1-167 (2010).
22. Mueller, J. E. et al. Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003. Emerg. Inf. Dis. 13, 847-854 (2007).
23. Wiesner, P. J. & Thompson, S. E. Gonococcal diseases. Disease-a-month 26, 1-44 (1980).
24. World Health Organization. Prevalence and incidence of selected sexually transmitted infections Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates (2011). Dept. of Reproductive Health and Research. ISBN: 978 92 4 150245 0.
25. Bostwick, H. A complete practical work on the nature and treatment of venereal diseases, and other affections of the genito-urinary organs of the male and female (Burgess, Stringer & Co., New York, 1848).
26. Brandt, A. M. No Magic Bullet: A Social History of Venereal Disease in the United States since 1880. (Oxford University Press, New York, 1985).
27. Hobbs, M. M., Seiler, A., Achtman, M. & Cannon, J. G. Microevolution within a clonal population of pathogenic bacteria-recombination, gene duplication and horizontal genetic exchange in the opa gene family of neisseria-meningitidis. Mol. Microbiol. 12, 171-180 (1994).
28. Callaghan, M. J. et al. Potential of Recombinant Opa Proteins as Vaccine Candidates against Hyperinvasive Meningococci. Infect. Immun. 79, 2810-2818 (2011).
29. Malorny, B., Morelli, G., Kusecek, B., Kolberg, J. & Achtman, M. Sequence diversity, predicted two-dimensional protein structure, and epitope mapping of neisserial Opa proteins. J. Bacteriol. 180, 1323-1330 (1998).
30. Johnson, D. R. et al. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J. Med. Microbiol. 55, 157-164 (2006).
31. Stern, A., Brown, M., Nickel, P. & Meyer, T. F. Opacity genes in Neisseria gonorrhoeae-control of phase and antigenic variation. Cell 47, 61-71 (1986).
32. Swanson, J., Barrera, O., Sola, J. & Boslego, J. Expression of outer-membrane protein-ii by gonococci in experimental gonorrhea. J. Exp. Med. 168, 2121-2129 (1988).
33. Jerse, A. E. et al. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179, 911-920 (1994).
34. Callaghan, M. J. et al. The effect of immune selection on the structure of the meningococcal Opa protein repertoire. Plos Pathog. 4, e1000080 (2008).
35. Bilek, N., Ison, C. A. & Spratt, B. G. Relative Contributions of Recombination and Mutation to the Diversification of the opa Gene Repertoire of Neisseria gonorrhoeae. J. Bacteriol. 191, 1878-1890 (2009).
36. Tettelin, H. et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287, 1809-1815 (2000).
37. Bhat, K. S. et al. The opacity proteins of neisseria-gonorrhoeae strain ms11 are encoded by a family of 11 complete genes. Mol. Microbiol. 5, 1889-1901 (1991).
38. Noble, R. C., Kirk, N. M., Slagel, W. A., Vance, B. J. & Somes, G. W. Recidivism among patients with gonococcal infection presenting to a venereal-disease clinic. Sex. Transm. Dis 4, 39-43 (1977).
39. Hedges, S., Mayo, M., Mestecky, J., Hook, E. & Russell, M. Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect. Immun. 67, 3937-3946 (1999).
40. Zak, K.,Diaz, J. L., Jackson,D.Heckels, J. E. Antigenic variation during infection with Neisseria-gonorrhoeae-detection of antibodies to surface-proteins in sera of patients with gonorrhea. J. Infect. Dis. 149, 166-174 (1984).
41. P Plummer, F. A. et al. antibodies to opacity proteins (opa) correlate with a reduced risk of gonococcal salpingitis. J. Clin. Invest. 93, 1748-1755 (1994).
42. Cole, J. G. & Jerse, A. E. Functional Characterization of Antibodies against Neisseria gonorrhoeae Opacity Protein Loops. Plos One 4, e8108 (2009).
43. Buchanan, T. M., Eschenbach, D. A., Knapp, J. S. & Holmes, K. K. Gonococcal salpingitis is less likely to recur with neisseria-gonorrhoeae of the same principal outer-membrane protein antigenic type. Am. J. Obstet. Gynecol. 138, 978-980 (1980).
44. Brooks, G. F. & Ingwer, I. Studies on relationships between serum bactericidal activity and uncomplicated genital infections due to neisseria-gonorrhoeae. J. Infect. Dis. 138, 333-339 (1978).
45. Castillochavez, C., Hethcote, H. W., Andreasen, V., Levin, S. A. & Liu, W. M. Epidemiological models with age structure, proportionate mixing, and crossimmunity. J. Math. Biol. 27, 233-258 (1989).
46. Buckee, C. O., Recker, M.,Watkins, E. R. & Gupta, S. Role of stochastic processes in maintaining discrete strain structure in antigenically diverse pathogen populations. Proc. Natl. Acad. Sci. USA 108, 15504-15509 (2011).
47. James, J. F. & Swanson, J. Studies on gonococcus infection .13. Occurrence of color-opacity colonial variants in clinical cultures. Infect. Immun. 19, 332-340 (1978).
48. Bos, M. P., Hogan, D. & Belland, R. J. Selection of Opa(1) Neisseria gonorrhoeae by limited availability of normal human serum. Infect. Immun. 65, 645-650 (1997).
49. Williams, J. M., Chen, G. C., Zhu, L. & Rest, R. F. Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth. Mol. Microbiol. 27, 171-186 (1998).
50. Muenzner, P., Rohde, M., Kneitz, S. & Hauck, C. R. CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. J. Cell Biol. 170, 825-836 (2005).
51. Pantelic, M. et al. Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production. Infect. Immun. 73, 4171-4179 (2005).
52. Boulton, I. C. & Gray-Owen, S. D. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4(1) T lymphocytes. Nat. Immunol. 3, 229-236 (2002).
53. Virji, M. et al. Critical determinants of host receptor targeting by Neisseria meningitidis and Neisseria gonorrhoeae: identification of Opa adhesiotopes on the N-domain of CD66 molecules. Mol. Microbiol. 34, 538-551 (1999).
54. Dehio, C., Gray-Owen, S. D. Meyer, T. F. The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol. 6, 489-495 (1998).
55. Wolff, K. & Stern, A. Identification and characterization of specific sequences encoding pathogenicity associated proteins in the genome of commensal neisseria species. Fems Microbiol. Lett. 125, 255-263 (1995).
56. T Toleman, M., Aho, E. & Virji, M. Expression of pathogen-like Opa adhesins in commensal Neisseria: genetic and functional analysis. Cell. Microbiol. 3, 33-44 (2001).
57. Bennett, J. S. et al. Genetic diversity and carriage dynamics of Neisseria lactamica in infants. Infect. Immun. 73, 2424-2432 (2005).
58. Bennett, J. S. et al. Species status of Neisseria gonorrhoeae: evolutionary and epidemiological inferences from multilocus sequence typing. BMC Biol. 5 (2007).
59. Trotter, C. L., Gay, N. J. & Edmunds, W. J. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am. J. Epidemiol. 162, 89-100 (2005).
60. Hethcote, H. W., Yorke, J. A. & Nold, A. Gonorrhea modeling-a comparison of control methods. Math. Biosci. 58, 93-109 (1982).